DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)

Conference proceeding

Peer reviewed

B Kasper, R Ratan, T Alcindor, P Schoeffski, WTA van der Graaf, B A Wilky, R F Riedel, A Lim, L M Smith, S Moody, …

2022-09

Abstract

Life Sciences & Biomedicine

Oncology

Science & Technology

status: published

1 Record Views

Title: DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)
Creators: B Kasper
R Ratan
T Alcindor
P Schoeffski
WTA van der Graaf
B A Wilky
R F Riedel
A Lim
L M Smith
S Moody
S Attia
S P Chawla
G D'Amato
N Federman
P Van Tine
B A Van Tine
B Vincenzi
S Kummar
M M Gounder
Publisher: ELSEVIER
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Conference proceeding
Record Identifier: 991031926792102976